Cargando…
Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia
MicroRNA (miRNA) expression is deregulated in many tumors including chronic lymphocytic leukemia (CLL). Although the particular mechanism(s) responsible for their aberrant expression is not well characterized, the presence of mutations and single-nucleotide polymorphisms (SNPs) in miRNA genes, possi...
Autores principales: | Kminkova, Jana, Mraz, Marek, Zaprazna, Kristina, Navrkalova, Veronika, Tichy, Boris, Plevova, Karla, Malcikova, Jitka, Cerna, Katerina, Rausch, Tobias, Benes, Vladimir, Brychtova, Yvona, Doubek, Michael, Mayer, Jiri, Pospisilova, Sarka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004199/ https://www.ncbi.nlm.nih.gov/pubmed/24306027 http://dx.doi.org/10.1093/carcin/bgt396 |
Ejemplares similares
-
P602: SINGLE-CELL RNA-SEQUENCING ENABLES TRACKING AND CHARACTERIZATION OF RARE CLL CELLS WITH THE POTENTIAL TO CAUSE REFRACTORINESS.
por: Kurucová, Terézia, et al.
Publicado: (2023) -
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
por: Olbertova, Helena, et al.
Publicado: (2022) -
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
por: Malcikova, Jitka, et al.
Publicado: (2021) -
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K(δ) inhibitor idelalisib
por: Sandova, Veronika, et al.
Publicado: (2021) -
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
por: Malcikova, J, et al.
Publicado: (2015)